Return On Equity of IMMUNIC, INC. from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
IMMUNIC, INC. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • IMMUNIC, INC. Return On Equity for the quarter ending 30 Sep 2025 was -716%, a 302% decline year-over-year.
  • IMMUNIC, INC. annual Return On Equity for 2024 was -194%, a 23% decline from 2023.
  • IMMUNIC, INC. annual Return On Equity for 2023 was -157%, a 60% decline from 2022.
  • IMMUNIC, INC. annual Return On Equity for 2022 was -99%, a 41% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

IMMUNIC, INC. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -716% -538% -302% 01 Jul 2025 30 Sep 2025
Q2 2025 -461% -292% -172% 01 Apr 2025 30 Jun 2025
Q1 2025 -327% -157% -92% 01 Jan 2025 31 Mar 2025
Q4 2024 -194% -37% -23% 01 Oct 2024 31 Dec 2024
Q3 2024 -178% -19% -12% 01 Jul 2024 30 Sep 2024
Q2 2024 -170% -37% -28% 01 Apr 2024 30 Jun 2024
Q1 2024 -170% -57% -50% 01 Jan 2024 31 Mar 2024
Q4 2023 -157% -59% -60% 01 Oct 2023 31 Dec 2023
Q3 2023 -159% -91% -135% 01 Jul 2023 30 Sep 2023
Q2 2023 -133% -71% -115% 01 Apr 2023 30 Jun 2023
Q1 2023 -113% -53% -90% 01 Jan 2023 31 Mar 2023
Q4 2022 -99% -29% -41% 01 Oct 2022 31 Dec 2022
Q3 2022 -68% -9% -15% 01 Jul 2022 30 Sep 2022
Q2 2022 -62% -9% -17% 01 Apr 2022 30 Jun 2022
Q1 2022 -60% -8% -14% 01 Jan 2022 31 Mar 2022
Q4 2021 -70% -31% -79% 01 Oct 2021 31 Dec 2021
Q3 2021 -59% -13% -27% 01 Jul 2021 30 Sep 2021
Q2 2021 -53% +5% +8.7% 01 Apr 2021 30 Jun 2021
Q1 2021 -52% +13% +20% 01 Jan 2021 31 Mar 2021
Q4 2020 -39% +39% +50% 01 Oct 2020 31 Dec 2020
Q3 2020 -46% +90% +66% 01 Jul 2020 30 Sep 2020
Q2 2020 -58% +725% +93% 01 Apr 2020 30 Jun 2020
Q1 2020 -66% -138% -191% 01 Jan 2020 31 Mar 2020
Q4 2019 -78% -135% -237% 01 Oct 2019 31 Dec 2019
Q3 2019 -136% -260% -209% 01 Jul 2019 30 Sep 2019
Q2 2019 -783% +119% +13% 01 Apr 2019 30 Jun 2019
Q1 2019 72% +229% 01 Jan 2019 31 Mar 2019
Q4 2018 57% +158% 01 Oct 2018 31 Dec 2018
Q3 2018 124% +195% 01 Jul 2018 30 Sep 2018
Q2 2018 -902% -835% -1264% 01 Apr 2018 30 Jun 2018
Q1 2018 -157% -95% -154% 01 Jan 2018 31 Mar 2018
Q4 2017 -101% -42% -71% 01 Oct 2017 31 Dec 2017
Q3 2017 -71% -19% -37% 01 Jul 2017 30 Sep 2017
Q2 2017 -66% -10% -18% 01 Apr 2017 30 Jun 2017
Q1 2017 -62% +3% +4.8% 01 Jan 2017 31 Mar 2017
Q4 2016 -59% +12% +17% 01 Oct 2016 31 Dec 2016
Q3 2016 -52% +21% +29% 01 Jul 2016 30 Sep 2016
Q2 2016 -56% +13% +19% 01 Apr 2016 30 Jun 2016
Q1 2016 -65% -5% -9.1% 01 Jan 2016 31 Mar 2016
Q4 2015 -71% +22% +24% 01 Oct 2015 31 Dec 2015
Q3 2015 -72% +204% +74% 01 Jul 2015 30 Sep 2015
Q2 2015 -69% 01 Apr 2015 30 Jun 2015
Q1 2015 -59% 01 Jan 2015 31 Mar 2015
Q4 2014 -93% 01 Oct 2014 31 Dec 2014
Q3 2014 -277% 01 Jul 2014 30 Sep 2014

IMMUNIC, INC. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -194% -37% -23% 01 Jan 2024 31 Dec 2024
2023 -157% -59% -60% 01 Jan 2023 31 Dec 2023
2022 -99% -29% -41% 01 Jan 2022 31 Dec 2022
2021 -70% -31% -79% 01 Jan 2021 31 Dec 2021
2020 -39% +39% +50% 01 Jan 2020 31 Dec 2020
2019 -78% -135% -237% 01 Jan 2019 31 Dec 2019
2018 57% +158% 01 Jan 2018 31 Dec 2018
2017 -101% -42% -71% 01 Jan 2017 31 Dec 2017
2016 -59% +12% +17% 01 Jan 2016 31 Dec 2016
2015 -71% +22% +24% 01 Jan 2015 31 Dec 2015
2014 -93% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.